- In October 2023, Abbott, a leader in medical technology, announced its acquisition of Tendyne Holding, Inc. This strategic acquisition strengthens Abbott's structural heart portfolio by incorporating transcatheter mitral valve replacement (TMVR) therapies. The move enhances Abbott’s ability to offer advanced heart valve solutions and expand its presence in the structural heart market
- In August 2023, Zimmer Biomet introduced the Persona Q-Fix Femoral System, a significant advancement in minimally invasive total hip arthroplasty (THA). This innovative system is designed to enhance surgical efficiency and offer surgeons better control with a more streamlined approach. The launch marks a key development in improving patient outcomes and simplifying the THA procedure
- In May 2023, Johnson & Johnson's Medical Devices segment announced a partnership with Cardiovascular Imaging Solutions (CIS) to develop and commercialize a next-generation intravascular imaging system for peripheral vascular interventions. The collaboration leverages CIS’s expertise in optical coherence tomography (OCT) technology alongside Johnson & Johnson’s strengths in medical device development and commercialization. This alliance aims to advance imaging capabilities and improve patient outcomes in peripheral vascular procedures
- In April 2023, CRS Holdings Inc. and Bioventus LLC merged to form a single entity under the Bioventus name, marking a significant milestone in the biomaterials market. This merger is set to create a global leader in orthobiologic and soft tissue solutions, capitalizing on synergies in R&D, manufacturing, and distribution. The unified company aims to drive innovation, particularly in the cardiovascular biomaterial sector
- In February 2023, Covestro introduced Makrolon 3638 polycarbonate, designed for healthcare and life science applications. This durable polycarbonate grade is engineered to withstand daily use while maintaining its structural integrity. The launch highlights Covestro's commitment to providing high-performance materials for critical medical and scientific uses
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Natural, Ceramic, Metallic, and Polymer), Product (Catheters, Stents, Implantable Cardiac Defibrillators, Pacemakers, Sensors, Heart Valves, Vascular Grafts, Guidewires, and Ventricular Assist Devices) – Industry Trends and Forecast to 2031
.
The Global Cardiovascular Biomaterial Market size was valued at USD 13.58 USD Billion in 2023.
The Global Cardiovascular Biomaterial Market is projected to grow at a CAGR of 6.72% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
